lodoxamide (Alomide)
Jump to navigation
Jump to search
Introduction
Tradenames: Alomide.
Indications
- treatment of vernal keratoconjunctivitis, vernal conjunctivitis, & vernal keratitis
Contraindications
Caution: NOT for use in patients wearing soft contact lenses
Dosage
- adults & children > 2 years of age:
- 1-2 drops QID for up to 3 months
Solution: 0.1% (10 mL)
Adverse effects
- common (> 10%)
- less common (1-10%)
- uncommon (< 1%)
- dizziness, somnolence, rash, nausea, stomach discomfort, blepharitis, sneezing, dry nose
- other
- crystalline deposits
Mechanism of action
- mast-cell stabilizer that inhibits type-1 immediate hypersentivity reaction
More general terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998